Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Obseva Sa Ordinary Shares (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

ObsEva SA / ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis . Processed and transmitted by Nasdaq Corporate...

OBSV : 19.43 (+33.54%)
ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018

ObsEva SA / ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18,...

OBSV : 19.43 (+33.54%)
New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Novo Nordisk A/S, HudBay Minerals, Tecnoglass, and Endeavour Silver -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ObsEva SA (NASDAQ:OBSV), Gran...

OBSV : 19.43 (+33.54%)
HBM : 6.35 (-0.78%)
NVO : 44.72 (-0.27%)
GTE : 3.23 (+1.57%)
EXK : 3.19 (-0.31%)
TGLS : 8.86 (+0.34%)
ObsEva SA to Seek SIX Share Listing

ObsEva SA / ObsEva SA to Seek SIX Share Listing . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

OBSV : 19.43 (+33.54%)
ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018

ObsEva SA / ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 19.43 (+33.54%)
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018

ObsEva SA / ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

ObsEva SA / ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109) . Processed...

OBSV : 19.43 (+33.54%)
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City

ObsEva SA / ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

OBSV : 19.43 (+33.54%)
Analysis: Positioning to Benefit within Fortress Transportation and Infrastructure Investors, Turquoise Hill Resources, FactSet Research, Shaw Communications, El Pollo Loco, and ObsEva SA -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fortress Transportation and...

TRQ : 2.78 (+0.72%)
OBSV : 19.43 (+33.54%)
FDS : 214.04 (+0.39%)
FTAI : 18.16 (-0.38%)
SJR : 21.00 (-0.19%)
LOCO : 10.85 (unch)
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018

ObsEva SA / ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

ObsEva SA / ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

ObsEva SA / ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018

ObsEva SA / ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

OBSV : 19.43 (+33.54%)
ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting

ObsEva SA / ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is...

OBSV : 19.43 (+33.54%)
ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF

ObsEva SA / ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018

ObsEva SA / ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons

ObsEva SA / Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 19.43 (+33.54%)
ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018

ObsEva SA / ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 19.43 (+33.54%)
ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis

ObsEva SA / ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis . Processed and transmitted by Nasdaq Corporate...

OBSV : 19.43 (+33.54%)
ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November

ObsEva SA / ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November . Processed...

OBSV : 19.43 (+33.54%)

Van Meerten Stock Picks

5 Great Large Caps
This morning I wanted to find 5 Large Cap stocks that had performed well over the last year and still appeared to have some juice left in them.
ABMD +1.07 , NFLX -1.83 , VLO +2.22 , RL +1.28 , ALGN +4.22
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures are trading 3 to 4 cents lower at the moment. They closed with most nearby contracts 1 to 2 cents lower on Friday, despite showing gains at midday. Front month July lost 4.37% on the week. Heavy rains are expected in much of the Corn Bel...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar